ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Pfizer’s Xeljanz secures marketing authorisation in Europe
August 06, 2018Pfizer has received approval from the European Commission (EC) to market Xeljanz (tofacitinib citrate) for the treatment of adults suffering from severely active ulcerative colitis (UC). -
EC amends marketing authorisation for Pharming’s Ruconest to include self-administration
January 18, 2017The European Commission (EC) has amended the marketing authorisation for Netherlands-based Pharming Group’s Ruconest (recombinant C1 esterase inhibitor) to include self administration using the Ruconest administration kit.
Pharma Sources Insight January 2025
